Stephen E. Sallan
Impact in
-
- Acute Lymphoblastic Leukemia research
- Hematology top 0.2%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
Papers in
-
- Acute Lymphoblastic Leukemia research 222
- Hematology 24
- Hematopoietic Stem Cell Transplantation 17
- Co-authors
- Richard D. Gelber (47 shared papers)Lewis B. Silverman (116 shared papers)Steven E. Lipshultz (36 shared papers)Steven D. Colan (20 shared papers)Nancy J. Tarbell (40 shared papers)Donna S Neuberg (77 shared papers)Stuart R. Lipsitz (14 shared papers)Scott A. Armstrong (16 shared papers)
- Journals
- Blood (73 papers)Journal of Clinical Oncology (34 papers)Cancer (23 papers)Pediatric Blood & Cancer (18 papers)Leukemia (9 papers)
- Partner nations
- United StatesCanadaNetherlands
In The Last Decade
Stephen E. Sallan
332 papers receiving 29.8k citations
Stephen E. Sallan's Hit Papers
Peers
Comparison fields: 5 of 155
- Public Health, Environmental and Occupational Health 11.7k
- Hematology 3.3k
- Cardiology and Cardiovascular Medicine 4.7k
- Genetics 1.4k
- Pediatrics, Perinatology and Child Health 1.9k
Countries citing papers authored by Stephen E. Sallan
This map shows the geographic impact of Stephen E. Sallan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen E. Sallan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen E. Sallan more than expected).
Fields of papers citing papers by Stephen E. Sallan
This network shows the impact of papers produced by Stephen E. Sallan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen E. Sallan. The network helps show where Stephen E. Sallan may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen E. Sallan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 338 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia Hit paper breakdown → | 2001 | 1465 |
| 2 | Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood Hit paper breakdown → | 1991 | 1158 |
| 3 | Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. Hit paper breakdown → | 1996 | 750 |
| 4 | Female Sex and Higher Drug Dose as Risk Factors for Late Cardiotoxic Effects of Doxorubicin Therapy for Childhood Cancer Hit paper breakdown → | 1995 | 677 |
| 5 | An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element Hit paper breakdown → | 2014 | 632 |
| 6 | Chronic Progressive Cardiac Dysfunction Years After Doxorubicin Therapy for Childhood Acute Lymphoblastic Leukemia Hit paper breakdown → | 2005 | 575 |
| 7 | 2011 | 503 | |
| 8 | 2004 | 501 | |
| 9 | 2000 | 486 | |
| 10 | Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. | 1997 | 466 |
| 11 | Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions Hit paper breakdown → | 2013 | 453 |
| 12 | 2006 | 432 | |
| 13 | Second malignant neoplasms in children: an update from the Late Effects Study Group. Hit paper breakdown → | 1985 | 426 |
| 14 | High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia Hit paper breakdown → | 2009 | 378 |
| 15 | 1984 | 376 | |
| 16 | 2010 | 359 | |
| 17 | 1986 | 353 | |
| 18 | 2006 | 349 | |
| 19 | 2003 | 343 | |
| 20 | Clinicopathologic Features and Long-term Outcomes of NUT Midline Carcinoma Hit paper breakdown → | 2012 | 324 |
About Stephen E. Sallan
Stephen E. Sallan is a scholar working on Public Health, Environmental and Occupational Health, Hematology, Genetics, Cardiology and Cardiovascular Medicine and Pediatrics, Perinatology and Child Health, having authored 338 papers that have together received 31.8k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (222 papers), Chemotherapy-induced cardiotoxicity and mitigation (29 papers), Hematopoietic Stem Cell Transplantation (17 papers), Childhood Cancer Survivors' Quality of Life (16 papers), Glioma Diagnosis and Treatment (14 papers), Multiple and Secondary Primary Cancers (9 papers), Nausea and vomiting management (7 papers) and Renal and related cancers (7 papers). The work is most often cited by research in Public Health, Environmental and Occupational Health (11.7k citations), Hematology (3.3k citations), Cardiology and Cardiovascular Medicine (4.7k citations), Genetics (1.4k citations) and Pediatrics, Perinatology and Child Health (1.9k citations). Stephen E. Sallan has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Richard D. Gelber, Lewis B. Silverman, Steven E. Lipshultz, Steven D. Colan, Nancy J. Tarbell, Donna S Neuberg, Stuart R. Lipsitz, Scott A. Armstrong, Harvey J. Cohen and Barbara L. Asselin. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cancer, Pediatric Blood & Cancer and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.